THE NHS’s latest fat jab is the strongest one so far, a study suggests.
A review of 22 studies found tirzepatide helped patients lose 5kg more than semaglutide, known as Wegovy or Ozempic.
The drug, made by Eli Lilly, was approved for use in diabetic NHS patients earlier this month.
Dr Thomas Karagiannis, of Aristotle University of Thessaloniki in Greece, said: “Tirzepatide was more effective for weight loss than semaglutide.”
Like semaglutide, tirzepatide was developed as a diabetes drug but manufacturers noticed it also helped patients lose weight.